https://lucyrx.com/wp-content/uploads/2026/10/featured-image-3.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-10-22 14:27:012026-10-22 14:43:11What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?Guides & Toolkits

Evaluate Your PBM With Confidence—And Protect Your People, Budget, and Bottom Line
This PBM Reform Readiness Checklist helps HR and benefits leaders evaluate their PBM partner against new reform standards—before compliance gaps, hidden fees, or fiduciary risks show up in your audit.
Use it to pressure-test your current setup, protect your employees, and stay ahead of what’s next. If your PBM isn’t built for reform, your plan—and your people—aren’t protected.
See How LucyRx Compares to Your Current PBM
Take 15 minutes to discover what transparency, integrity, and real alignment can look like. We’re not just ready for reform—we were built for it.
Recommended Reads
https://lucyrx.com/wp-content/uploads/2026/10/featured-image-3.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-10-22 14:27:012026-10-22 14:43:11What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?
When Women’s Health Reaches the Prescription, the Pharmacy Benefit Still Has Work to Do
Women’s health programs can improve clinical access, but prescription barriers can still interrupt treatment. Employers and benefits leaders should evaluate affordability, coverage, medication availability and how quickly access problems are resolved.

PBM Flexibility Is Not the Same as Control: What TPAs Should Test
Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.

Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM
A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.

How Should a Specialty Pharmacy Earn Its Role?
Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

Projected Savings vs. Realized Savings: What Employers Should Ask
Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.

A Better Way to Think About GLP-1 Strategy
GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.

Diabetes Affordability is About More Than One Prescription
Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.

Is Your Pharmacy Benefit Still Working as Intended?
A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.

Disclosure Won. Now What?
PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.

What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?
Third-party administrators put their own client relationships at stake when recommending a pharmacy benefit manager. Learn which capabilities help TPAs evaluate PBM partners, explain benefit strategies confidently and maintain accountability from implementation through renewal.

When Women’s Health Reaches the Prescription, the Pharmacy Benefit Still Has Work to Do
Women’s health programs can improve clinical access, but prescription barriers can still interrupt treatment. Employers and benefits leaders should evaluate affordability, coverage, medication availability and how quickly access problems are resolved.

PBM Flexibility Is Not the Same as Control: What TPAs Should Test
Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.

Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM
A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.

How Should a Specialty Pharmacy Earn Its Role?
Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

Projected Savings vs. Realized Savings: What Employers Should Ask
Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.

A Better Way to Think About GLP-1 Strategy
GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.

Diabetes Affordability is About More Than One Prescription
Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.

Is Your Pharmacy Benefit Still Working as Intended?
A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.

Share